The optics of this are terrible and the US should be working with other countries. But my guess is even if the US worked with Europe on distribution >90% of it would go to the US anyway. The need stateside is exponentially greater.
My guess is that Gilead played Trump and will now backtrack to make a licensing deal so that the EU can produce its own at a lower price.
There’s nothing stopping Gilead from allowing more licensing now that it has squeezed all it can from its best customer.
Comments
The optics of this are terrible and the US should be working with other countries. But my guess is even if the US worked with Europe on distribution >90% of it would go to the US anyway. The need stateside is exponentially greater.
My guess is that Gilead played Trump and will now backtrack to make a licensing deal so that the EU can produce its own at a lower price.
There’s nothing stopping Gilead from allowing more licensing now that it has squeezed all it can from its best customer.